Billionaires Holding RDUS

BILLIONAIRE ALLOCATION SHARES OWNED (M) % CO AVG. COST RETURN

FUNDAMENTALS

  • N/A
    PE

  • 0.0
    Yield

  • 32.9M
    Shares Outstanding

  • 1.92B
    Market Cap

News & Insights

ABOUT

RDUS

Radius Health, Inc., a biopharmaceutical company, focuses on developing novel therapeutics for patients with osteoporosis and other serious endocrine-mediated diseases in the United States. Its lead product includes abaloparatide (BA058), a novel synthetic peptide analog of parathyroid hormone-re...

Google parent Alphabet's earnings: $8.42 per share, vs expected EPS of $8.04

NEWS

Amazon keeps its crown as king of cloud as sales pop

READ MORE